CIA
GOSS icon

Caerus Investment Advisors’s Gossamer Bio GOSS Stock Holding History

Caerus Investment Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.89K Buy
+11,839
New +$18.6K ﹤0.01% 281

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Caerus Investment Advisors's GOSS Position: Q1 2026 in Review

Caerus Investment Advisors opened a new position in Gossamer Bio (GOSS) in Q1 2026: 11,839 shares worth $3.89K. The stake represents ﹤0.01% of the portfolio and ranks #281 among its holdings.

184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Caerus Investment Advisors held 11,839 shares of Gossamer Bio worth $3.89K as of Q1 2026.
  • Gossamer Bio was a new Caerus Investment Advisors position in Q1 2026.
  • Gossamer Bio made up ﹤0.01% of Caerus Investment Advisors's portfolio in Q1 2026, its #281 holding.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.